Back
Analog Devices 10K Form
Buy
57
ADI
Analog Devices
Last Price:
$218.10
Seasonality Move:
16.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-22 | 10Q | ADI/Analog Devices Quarterly |
2024-02-21 | 10Q | ADI/Analog Devices Quarterly |
2023-11-21 | 10K | ADI/Analog Devices Annual |
2023-08-23 | 10Q | ADI/Analog Devices Quarterly |
2023-05-24 | 10Q | ADI/Analog Devices Quarterly |
2023-02-15 | 10Q | ADI/Analog Devices Quarterly |
Receive ADI News And Ratings
See the #1 stock for the next 7 days that we like better than ADI
ADI Financial Statistics
Sales & Book Value
Annual Sales: | $9.4B |
---|---|
Cash Flow: | $885.4M |
Price / Cash Flow: | 34.33 |
Annual Sales: | $70.85 |
Price / Book: | 3.03 |
Profitability
EPS (TTM): | 3.29000 |
---|---|
Net Income (TTM): | $1.6B |
Gross Margin: | $5.4B |
Return on Equity: | 4.63% |
Return on Assets: | 3.37% |
Analog Devices Earnings Forecast
Key Analog Devices Financial Ratios
-
The Gross Profit Margin over the past 41 years for ADI is 57.08%.
-
The Selling, General & Administrative Expenses for ADI have been equal to 11.34% of Gross Profit Margin.
-
The Research & Development expenses have been 15.78% of Revenue.
-
The Interest Expense is 19.70% of Operating Income.
-
The Net Earning history of ADI is 17.35% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 24 years.
Analog Devices Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | ADI |
CUSIP: | 032654 |
Website: | analog.com |
Debt
Debt-to-Equity Ratio: | 0.22 |
---|---|
Current Ratio: | 1.84 |
Quick Ratio: | 1.24 |
Price-to-Earnings
Trailing P/E Ratio: | 65.52 |
---|---|
Forward P/E Ratio: | 23.92 |
ADI Technical Analysis vs Fundamental Analysis
Buy
57
Analog Devices (ADI)
is a Buy
Is Analog Devices a Buy or a Sell?
-
Analog Devices stock is rated a BuyThe current Analog Devices [ADI] share price is $214.89. The Score for ADI is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.